Full Bio Michael Alt has been appointed to the Court in June 2023. His technical focus is in the following areas: pharma, biotech, chemistry, medical devices. Technical focuspharma, biotech, chemistry, medical devicesApril 2001 – April 2006: German and European patent and trademark attorney at the vaccine-focused biopharmaceutical company Bavarian Nordic GmbH, MartinsriedNovember 2001: Entry on the list of professional representatives before the European patent officeOctober 2001: Entry on the list of professional representatives before the Office for harmonization in the internal marketSeptember 2001: Entry on the list of German patent attorneysFebruary 1997 – January 2001: Patent attorney traineeStudies of law for patent attorneys at the Fernuniversität Hagen Professional Experience in Intellectual PropertyMay 2006 – present: German and European patent and trademark attorney at Bird & Bird LLP, Munich; current position: partner Professional Experience in ScienceMay 1993 – January 1997: Max-Planck-Institute for Biochemistry, Department of Virus Research; research focus: hepatitis C virus therapies, hepatitis B virus, antisense oligonucleotides and ribozymes, gene therapy based on AAV vectors. EducationNovember 1988 – December 1992: Ph.D. thesis in molecular virus research at the Institute for Clinical and Molecular Virus Research, University of Erlangen-Nürnberg, Germany.November 1982 – October 1988: Studies of biology with a focus on biochemistry, virology, organic chemistry and zoology at the University of Erlangen-Nürnberg; research at the Institut de Biologie Moléculaire et Cellulaire du CNRS, Strasbourg, France. Diploma in biology Name of any other employer of the judge or administration/court the judge is serving for Bird & Bird LLP
Full Bio Michael Alt has been appointed to the Court in June 2023. His technical focus is in the following areas: pharma, biotech, chemistry, medical devices. Technical focuspharma, biotech, chemistry, medical devicesApril 2001 – April 2006: German and European patent and trademark attorney at the vaccine-focused biopharmaceutical company Bavarian Nordic GmbH, MartinsriedNovember 2001: Entry on the list of professional representatives before the European patent officeOctober 2001: Entry on the list of professional representatives before the Office for harmonization in the internal marketSeptember 2001: Entry on the list of German patent attorneysFebruary 1997 – January 2001: Patent attorney traineeStudies of law for patent attorneys at the Fernuniversität Hagen Professional Experience in Intellectual PropertyMay 2006 – present: German and European patent and trademark attorney at Bird & Bird LLP, Munich; current position: partner Professional Experience in ScienceMay 1993 – January 1997: Max-Planck-Institute for Biochemistry, Department of Virus Research; research focus: hepatitis C virus therapies, hepatitis B virus, antisense oligonucleotides and ribozymes, gene therapy based on AAV vectors. EducationNovember 1988 – December 1992: Ph.D. thesis in molecular virus research at the Institute for Clinical and Molecular Virus Research, University of Erlangen-Nürnberg, Germany.November 1982 – October 1988: Studies of biology with a focus on biochemistry, virology, organic chemistry and zoology at the University of Erlangen-Nürnberg; research at the Institut de Biologie Moléculaire et Cellulaire du CNRS, Strasbourg, France. Diploma in biology Name of any other employer of the judge or administration/court the judge is serving for Bird & Bird LLP